Hypocalcemia — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for hypocalcemia. 27 active patents protecting 3 drugs from 1+ originators. First major cliff: 2037. Daily refresh.

3
Approved drugs
27
Active US patents
62/100
Avg vulnerability
—
Annual revenue covered

Originators in Hypocalcemia

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Fresenius Medcl Care 3 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating hypocalcemia. Each bar = one year. Y-axis scaled to peak year (8 patents).

5
27
8
28
2
30
4
34
8
37

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Rayaldee
CALCIFEDIOL
 — 16 65 — 2027-02-02
Calcium Gluconate
CALCIUM GLUCONATE
 — 8 45 — 2037-07-25
Phoslo
CALCIUM ACETATE
 Fresenius Medcl Care 3 76 — 2027-07-20

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
9943530 Rayaldee method of use 80 2027-02-02
8592480 Phoslo method of use 80 2027-07-20
11801253 Rayaldee method of use 76 2030-09-07
9089528 Phoslo method of use 75 2027-07-20
8778373 Rayaldee method of use 75 2028-04-25
8207149 Rayaldee method of use 75 2028-04-25
11154509 Rayaldee method of use 75 2028-04-25
9498486 Rayaldee method of use 75 2028-04-25
9408858 Rayaldee method of use 75 2028-04-25
9925147 Rayaldee method of use 75 2028-04-25

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10130646 Calcium Gluconate formulation 42 2037-07-25
10342813 Calcium Gluconate formulation 42 2037-07-25
10130646 Calcium Gluconate formulation 42 2037-07-25
10130646 Calcium Gluconate formulation 42 2037-07-25
10342813 Calcium Gluconate formulation 42 2037-07-25
10342813 Calcium Gluconate formulation 42 2037-07-25
10357502 Rayaldee formulation 42 2034-03-14
9861644 Rayaldee formulation 42 2034-03-14
10300078 Rayaldee formulation 42 2034-03-14
11253528 Rayaldee formulation 50 2034-03-14

Related